The Future of Pharmacy in Morocco: Challenges and Opportunities
Deciphering the “Third-Party Guaranteed” Agreement
The debate intensifying around Morocco’s pharmaceutical sector’s future highlights significant tensions with the so-called “Third-Party Guaranteed” (TPA) agreement. The National Federation of Pharmacists Association has denounced the agreement’s current iteration, citing unmet commitments. Notable omissions include continuous training provisions and the establishment of tracking committees, leading to dissatisfaction and calls for reform.
Such omissions, particularly those outlined in clauses 111 and 112, indicate a widespread lack of commitment from involved parties. Consequently, pharmacists like Nabil Bennani express concerns over sustainable business practices, highlighting a dire need for equitable profit margins.
Profit Margins and Market Fairness
Low profit margins persist despite the high cost of certain pharmaceuticals. A 1000-dirham medication often yields a pharmacist a mere 300 to 400 dirhams in profit. For far more expensive drugs, costing up to 20,000 dirhams, the profit remains disproportionately low. This imbalance challenges pharmacists’ economic sustainability and raises questions about fair market practices.
Beyond financial concerns, unethical practices include collaborations between pharmacists and private labs, favoring certain patients. Such practices exacerbate inequality within the profession and call for immediate rectification.
Strategic Actions and Solutions
In response to these growing pressures, the National Federation has decided to halt the extension of TPA until palpable assurances are provided by the Ministry of Health and Social Protection, along with insurance bodies like CNSS. They assert that decisions cannot be made unilaterally, without considering the economic struggles faced by pharmacists.
Modernization through Digitalization
Further frustrations arise from the planned digitization of prescriptions. The federation insists that digitalization must be comprehensive, involving all pharmacies and supported by updated legal frameworks. This requires a robust technological infrastructure to handle the transition effectively.
Addressing Controlled Substance Security
Concerns also touch upon the distribution of potent drugs. Without stringent controls, these substances can easily escape institutional oversight, potentially fueling illicit markets. Stringent tracking and surveillance, including digital tracking and video monitoring, are strongly advocated by the federation.
Joint Stakeholder Dialogue
For lasting solutions, a comprehensive national dialogue including the Ministry of Health, professional associations, and insurance entities is essential. Such cooperation is crucial for crafting balanced solutions that sustain healthcare initiatives previously championed by King Mohammed VI.
Looking Ahead: Equitable Agreements
Any new agreements must anchor economic fairness, ensuring that neither financial pressures nor training deficiencies undermine pharmacists’ roles. Equitable commitments among stakeholders will facilitate professional continuity and secure public service quality.
Frequently Asked Questions
What are the primary criticisms of the TPA agreement?
The TPA agreement is criticized for failing to uphold its provisions, particularly regarding training and committee setups for patient management.
How do low profit margins affect pharmacists?
Pharamacists earn minimal returns on high-cost medications, challenging their economic sustainability.
What are the steps being taken to modernize the sector?
Steps include advocating for complete digitalization of prescriptions and ensuring robust cybersecurity for controlled substances.
Explore More Insights
For more insights into Morocco’s evolving healthcare policies, explore our extensive coverage on the topic. Visit here to deepen your understanding.
Would you like to discuss these issues further? Share your thoughts or subscribe to updates.
